Troglitazone induction of COX-2 expression is dependent on ERK activation in keratinocytes

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 74, Issue 3, 2006, Pages 193-197

  He, Guobin ^a   Sung, You Me ^a   Fischer, Susan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIDIABETIC AGENT; BEZAFIBRATE; CORIOLIC ACID; CYCLOOXYGENASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; PROSTAGLANDIN E2; ROSIGLITAZONE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CHROMANS; CYCLOOXYGENASE 2; DINOPROSTONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE EXPRESSION; KERATINOCYTES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHORYLATION; PPAR GAMMA; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; THIAZOLIDINEDIONES;

ANIMALIA;

EID: 33644847189     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.12.001     Document Type: Article

References (27)

1. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J. Biol. Chem. 270 1995 12953 12956
2. B.M. Forman, P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma Cell 83 1995 803 812
3. L. Fajas, M.B. Debril, and J. Auwerx Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis J. Mol. Endocrinol. 27 2001 1 9
4. S. Altiok, M. Xu, and B.M. Spiegelman PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A Genes Dev. 11 1997 1987 1998
5. S.S. Palakurthi, H. Aktas, L.M. Grubissich, R.M. Mortensen, and J.A. Halperin Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation Cancer Res. 61 2001 6213 6218
6. G. He, P. Thuillier, and S.M. Fischer Troglitazone inhibits cyclin D1 expression and cell cycling independently of PPARgamma in normal mouse skin keratinocytes J. Invest. Dermatol. 123 2004 1110 1119
7. G. He, Y.M. Sung, J. DiGiovanni, S.M. Fischer, Thiazolidinediones inhibit insulin-like growth factor 1 (IGF-1) induced activation of p70S6 kinase and suppress IGF-1 tumor promoting activity, Cancer Res., 2006, in press.
8. G. He, S.J. Muga, P. Thuillier, R.A. Lubet, and S.M. Fischer The effect of PPARgamma ligands on UV- or chemically induced carcinogenesis in mouse skin Mol. Carcinogen. 43 2005 198 206
9. S.M. Fischer Is cyclooxygenase-2 important in skin carcinogenesis? J. Environ. Pathol. Toxicol. Oncol. 21 2002 183 191
10. K. Müller-Decker, G. Neufang, I. Berger, M. Neumann, F. Marks, and G. Furstenberger Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis Proc. Natl. Acad. Sci. USA 99 2002 12483 12488
11. S.M. Fischer, H.H. Lo, and G.B. Gordon Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis Mol. Carcinogen. 25 1999 231 240
12. S.M. Fischer, C.J. Conti, J. Viner, C.M. Aldaz, and R.A. Lubet Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice Carcinogenesis 24 2003 945 952
13. K. Subbaramaiah, D.T. Lin, J.C. Hart, and A.J. Dannenberg Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300 J. Biol. Chem. 276 2001 12440 12448
14. W.L. Yang, and H. Frucht Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells Carcinogenesis 22 2001 1379 1383
15. M.Y. Li, H. Deng, J.M. Zhao, D. Dai, and X.Y. Tan PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells World J. Gastroenterol. 9 2003 1220 1226
16. D. Bishop-Bailey, and T.D. Warner PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist Faseb J. 17 2003 1925 1927
17. A.V. Pontsler, A. St Hilaire, G.K. Marathe, G.A. Zimmerman, and T.M. McIntyre Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein J. Biol. Chem. 277 2002 13029 13036
18. L. Nagy, P. Tontonoz, J.G. Alvarez, H. Chen, and R.M. Evans Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma Cell 93 1998 229 240
19. M. Gurnell, J.M. Wentworth, and M. Agostini A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis J. Biol. Chem. 275 2000 5754 5759
20. W. Xie, and H.R. Herschman Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum J. Biol. Chem. 271 1996 31742 31748
21. S.T. Reddy, D.J. Wadleigh, and H.R. Herschman Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells J. Biol. Chem. 275 2000 3107 3113
22. J.X. Chen, L.C. Berry, B.W. Christman, and B. Meyrick Glutathione mediates LPS-stimulated COX-2 expression via early transient p42/44 MAPK activation J. Cell Physiol. 197 2003 86 93
23. J.L. Dean, M. Brook, A.R. Clark, and J. Saklatvala p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes J. Biol. Chem. 274 1999 264 269
24. B.R. Kelemen, K. Hsiao, and S.A. Goueli Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides J. Biol. Chem. 277 2002 8741 8748
25. A.L. Sabichi, V. Subbarayan, N. Llansa, S.M. Lippman, and D.G. Menter Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells Cancer Epidemiol. Biomarkers Prev. 13 2004 1704 1709
26. E.A. Meade, T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells J. Biol. Chem. 274 1999 8328 8334
27. H.F. Tiano, C.D. Loftin, and J. Akunda Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis Cancer Res. 62 2002 3395 3401